202 related articles for article (PubMed ID: 27644895)
1. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG
Song XL; Liu S; Jiang Y; Gu LY; Xiao Y; Wang X; Cheng L; Li XT
Eur J Pharm Sci; 2017 Jan; 96():129-140. PubMed ID: 27644895
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells.
Li XT; Tang W; Jiang Y; Wang XM; Wang YH; Cheng L; Meng XS
Oncotarget; 2016 Apr; 7(17):24604-22. PubMed ID: 27029055
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma.
Li XT; Tang W; Xie HJ; Liu S; Song XL; Xiao Y; Wang X; Cheng L; Chen GR
J Liposome Res; 2019 Mar; 29(1):21-34. PubMed ID: 29166813
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
7. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
8. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
10. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
[TBL] [Abstract][Full Text] [Related]
11. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation.
Zhang P; Hu L; Yin Q; Zhang Z; Feng L; Li Y
J Control Release; 2012 May; 159(3):429-34. PubMed ID: 22306333
[TBL] [Abstract][Full Text] [Related]
12. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma.
Ju RJ; Zeng F; Liu L; Mu LM; Xie HJ; Zhao Y; Yan Y; Wu JS; Hu YJ; Lu WL
Int J Nanomedicine; 2016; 11():1131-46. PubMed ID: 27042063
[TBL] [Abstract][Full Text] [Related]
13. Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment.
Li XY; Wang JH; Gu LY; Yao XM; Cai FY; Jing M; Li XT; Ju RJ
J Drug Target; 2020 Dec; 28(10):1071-1084. PubMed ID: 32484364
[TBL] [Abstract][Full Text] [Related]
14. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
[TBL] [Abstract][Full Text] [Related]
15. Development of pegylated liposomal vincristine using novel sulfobutyl ether cyclodextrin gradient: is improved drug retention sufficient to surpass DSPE-PEG-induced drug leakage?
Cui J; Li C; Wang C; Li Y; Zhang L; Zhang L; Xiu X; Li Y; Wei N
J Pharm Sci; 2011 Jul; 100(7):2835-48. PubMed ID: 21305545
[TBL] [Abstract][Full Text] [Related]
16. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
[TBL] [Abstract][Full Text] [Related]
17. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposome.
Lv Q; Li LM; Han M; Tang XJ; Yao JN; Ying XY; Li FZ; Gao JQ
Int J Pharm; 2013 Feb; 444(1-2):1-9. PubMed ID: 23347891
[TBL] [Abstract][Full Text] [Related]
20. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
